111, Inc.
Rank #199DeclineYI · Nasdaq · Healthcare
111, Inc. (YI) — Rank #199 by gross profitability (GP/assets 0.33) · ROE 9.5% · Piotroski F-Score 4 / 9.
As-of 2026-09-15 · CIK 0001738906 · all metrics point-in-time as of the filing date.
About
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.
Show moreShow less
It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc.
was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
- Industry
- Medical Distribution
- Sector
- Healthcare
- State
- E9
- Filer Category
- Non-accelerated filer
- Fiscal Year End
- December 31
- Website
- corporate.111.com.cn
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-04-30 | 2024-12-31filed 2025-04-29 | 2023-12-31filed 2024-05-14 | 2022-12-31filed 2023-04-28 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 11.8 | 17.0 | 21.8 | 40.8 |
| Stock-based compensation | 10.0 | 20.1 | 226.7 | 162.1 |
| Change in receivables | (153.4) | (123.7) | 47.9 | 84.4 |
| Change in inventory | (387.1) | (28.1) | (59.6) | 406.3 |
| Change in payables | — | — | — | — |
| Operating cash flow | 119.1 | 263.0 | (447.2) | (23.2) |
| Investing | ||||
| Capital expenditures | 4.5 | 15.2 | 9.8 | 31.6 |
| Investing cash flow | (53.7) | 37.4 | 151.7 | (47.2) |
| Financing | ||||
| Debt repaid | — | — | — | 249.6 |
| Share repurchases | — | — | — | — |
| Financing cash flow | (21.2) | (406.2) | 206.0 | 22.7 |
| Summary | ||||
| Free cash flow | 114.7 | 247.8 | (457.1) | (54.7) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?